MedKoo Cat#: 319916 | Name: Rabeximod

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Rabeximod, also known as ROB-803; is an immunomodulator agent. Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders. Rabeximod suppresses arthritis by preventing activation of inflammatory cells, most likely macrophages, in a time dependent fashion, downstream of TLR2 and TLR4 stimulation. Anti-inflammatory treatment of traumatic brain injury with Rabeximod reduces cerebral antigen presentation in mice.

Chemical Structure

Rabeximod
Rabeximod
CAS#872178-65-9

Theoretical Analysis

MedKoo Cat#: 319916

Name: Rabeximod

CAS#: 872178-65-9

Chemical Formula: C22H24ClN5O

Exact Mass: 409.1669

Molecular Weight: 409.92

Elemental Analysis: C, 64.46; H, 5.90; Cl, 8.65; N, 17.09; O, 3.90

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ROB-803; ROB-803; ROB-803; Rabeximod.
IUPAC/Chemical Name
2-(9-chloro-2,3-dimethyl-6H-indolo[2,3-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide
InChi Key
PDNNUMNEXITLCZ-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H24ClN5O/c1-13-9-17-18(10-14(13)2)26-22-21(25-17)16-11-15(23)5-6-19(16)28(22)12-20(29)24-7-8-27(3)4/h5-6,9-11H,7-8,12H2,1-4H3,(H,24,29)
SMILES Code
O=C(NCCN(C)C)CN(C1=NC2=CC(C)=C(C)C=C2N=C13)C4=C3C=C(Cl)C=C4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 409.92 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Israelsson C, Kylberg A, Björklund U, Ebendal T. Anti-inflammatory treatment of traumatic brain injury with Rabeximod reduces cerebral antigen presentation in mice. J Neurosci Res. 2015 Oct;93(10):1519-25. doi: 10.1002/jnr.23607. Epub 2015 Jun 10. PubMed PMID: 26068706. 2: Hultqvist M, Nandakumar KS, Björklund U, Holmdahl R. Rabeximod reduces arthritis severity in mice by decreasing activation of inflammatory cells. Ann Rheum Dis. 2010 Aug;69(8):1527-32. doi: 10.1136/ard.2009.121178. Epub 2010 Jun 11. PubMed PMID: 20542961. 3: Giusti P, Frascaroli G, Tammik C, Gredmark-Russ S, Söderberg-Nauclér C, Varani S. The novel anti-rheumatic compound Rabeximod impairs differentiation and function of human pro-inflammatory dendritic cells and macrophages. Immunobiology. 2011 Jan-Feb;216(1-2):243-50. doi: 10.1016/j.imbio.2010.04.004. Epub 2010 Apr 28. PubMed PMID: 20494473. 4: Hultqvist M, Nandakumar KS, Björklund U, Holmdahl R. The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders. Ann Rheum Dis. 2009 Jan;68(1):130-5. doi: 10.1136/ard.2007.085241. Epub 2008 Mar 17. PubMed PMID: 18347009.